Showing results (431-440 of 1,799) with videos related to
Sort By:
Pageof 180
Scandinavian Journal of Infectious Diseases|January 1, 1991
Effect of loracarbef on the normal oropharyngeal and intestinal microfloraC E Nord, A Grahnen, S A EckernäsJournal of Bacteriology|June 19, 2012
A Listeria monocytogenes RNA helicase essential for growth and ribosomal maturation at low temperatures uses its C terminus for appropriate interaction with the ribosomeSakura Netterling, Karolis Vaitkevicius, Stefan Nord, et al.Microbial Drug Resistance (Larchmont, N.Y.)|September 24, 2004
Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infectionsC E Nord, D J Farrell, R LeclercqArchives of Biochemistry and Biophysics|July 1, 1992
Rat lung polycholorinated biphenyl-binding protein: effect of glucocorticoids on the expression of the Clara cell-specific protein during fetal developmentM Nord, O Andersson, M Brönnegård, et al.Journal of Cell Science|February 28, 2013
Six1 regulates proliferation of Pax7-positive muscle progenitors in zebrafishHanna Nord, Lars Nygård Skalman, Jonas von HofstenScandinavian Journal of Infectious Diseases|January 1, 1985
Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infectionsI Nilsson-Ehle, C E Nord, B UrsingDevelopment (Cambridge, England)|May 31, 2024
DLX genes and proteins in mammalian forebrain developmentJohn L Rubenstein, Alex S Nord, Marc EkkerSouth Dakota Medicine : the Journal of the South Dakota State Medical Association|September 24, 2014
Sports concussion management: a review of the evidenceMark List, Mark Vukonich, Wesley Nord, et al.Anaerobe|December 3, 2014
Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacinMamun-Ur Rashid, Andrej Weintraub, Carl Erik NordEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1990
Comparative in vitro activity of the new oral cephalosporin Bay v 3522 against aerobic and anaerobic bacteriaM Rylander, C E Nord, S R NorrbyPageof 180